X0306 4 2021-12-28 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001164475 DANIELS RONALD J C/O BRIDGEBIO PHARMA, INC. 421 KIPLING STREET PALO ALTO CA 94301 1 0 0 0 Common Stock 2021-12-28 4 P 0 11745 12.73 A 11745 D Common Stock 2021-12-28 4 S 0 11745 12.80 D 0 D Common Stock 2021-12-30 4 P 0 10402 14.34 A 10402 D The Reporting Person realized short-swing profits under Section 16(b) of the Securities Exchange Act of 1934, as amended, as a result of the purchase and sale of the Issuer's common stock on December 28, 2021 reported herein. The Reporting Person has agreed to voluntarily disgorge to the Issuer all short-swing profits realized by the Reporting Person from such transactions. Represents the weighted average sale price of the shares sold from $12.7275 to $12.73 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions as reported in footnotes 2 and 3. Represents the weighted average sale price of the shares sold from $12.79 to $12.82 per share. Yi Ching Yau, Attorney-in-Fact 2021-12-30